Baxter Receives EMEA Positive Opinion for CELVAPAN, the First Cell Culture-based Pandemic Flu Vaccine
» read more
The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine
» read more
U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCīs DVC and Baxter
» read more
|